Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.707823
Title: Enhancing the solubility of BCS class II drugs using mesoporous silica based formulations
Author: Madi, Atif M. Abdelsaiad
ISNI:       0000 0004 6057 1817
Awarding Body: Queen's University Belfast
Current Institution: Queen's University Belfast
Date of Award: 2016
Availability of Full Text:
Full text unavailable from EThOS.
Please contact the current institution’s library for further details.
Abstract:
Over the last decade, the poor water solubility of new chemical entities has become a significant issue for the pharmaceutical industry. Adequate aqueous solubility levels are essential for drugs administered via the oral route to ensure appropriate therapeutic levels. Currently, different strategies have been developed to address the issue of poor aqueous solubility of drug compounds. Those strategies are based on either chemical or physical modifications where the later strategies are preferred to overcome the poor solubility issue. In this thesis, amorphous mesoporous silica particles were used as a novel platform that could function as a carrier, solubility enhancer and amorphous form stabiliser for the poorly water soluble drug, indomethacin (INM). The principal concept was to develop novel solid dispersions manufactured via several solvent-free methods using two grades of mesoporous silica particles. Materials were firstly examined for their thermal stability and crystallinity. PEGs polymers were investigated as potential solubiliser and carrier for INM particles in some hot melt extrusion (HME) studies. Polymer-free manufacturing techniques (supercritical fluid impregnation and ball milling) were employed to investigate the possibility of manufacturing amorphous solid dispersions with better dissolution performance. Moreover, it was possible to develop polymer-free extrudates with significantly improved dissolution rates using HME. All manufactured formulations showed a significant redaction in the crystalline contents and a significant enhancement in the dissolution performance relative to raw crystalline INM. The data obtained in this PhD thesis has shown that the incorporation of mesoporous silica carrier platforms may be successfully employed as an alternative approach to generating solid dispersions of amorphous drugs to enhance the solubility of poorly water soluble drugs.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.707823  DOI: Not available
Share: